Skip to content
healthcare.dev

Brivaracetam

NDC 14335-420, brivaracetam, injection, from Hainan Poly Pharm. Co., Ltd..

Product NDC
14335-420
Status
Listed
Labeler
Hainan Poly Pharm. Co., Ltd.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218249
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/14335-420 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BRIVARACETAM50 mg/5mL

Pharmacologic classes

Epoxide Hydrolase Inhibitors [MoA]

Package NDCNDC-11Package
14335-420-101433504201010 VIAL, GLASS in 1 CARTON (14335-420-10) / 5 mL in 1 VIAL, GLASS (14335-420-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3ea51292-fe03-46f5-9d9b-36986f5b7224

Use it

Look up 14335-420 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/14335-420 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 14335-420. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.